Coronavirus

RAND SLAM: Watch Paul Put Fauci on Defense, 'You're Giving Us Gobbledygook!'

posted by Hannity Staff - 9.14.22

Another classic Paul v. Fauci showdown.

During Wednesday’s Health, Education, Labor and Pensions Committee hearing, Kentucky Senator Rand Paul threatened a wave of oversight after Dr. Anthony Fauci refused to disclose whether or not members of the FDA have received royalties from companies that manufacture COVID-19 vaccines.

Paul wanted to establish a potential conflict of interest —but Fauci wasn’t budging.

“We’ve been asking you and you refuse to answer whether anybody on the vaccine committees gets royalties from the pharmaceutical companies,” Paul said. “I asked you last time and what was your response? ‘We don’t have to tell you.’”

According to The Daily Caller, “Paul said he then tried to obtain them by filing a request under the Freedom of Information Act (FOIA) and Fauci again rejected his request.”

“But I’ll tell you this, when we get in charge, we’re gonna change the rules and you will have to divulge where you get your royalties from, from what companies, and if anybody on the committee has a conflict of interest. We’re gonna learn about it. I promise you that.”

“Over the period of time from 2010 to 2016, 27,000 royalty payments were paid to 18,000 NIH employees,” Paul told Fauci, according to KATV. “We know that not because you told us, but because we forced you to tell us through the Freedom of Information Act. Over $193 million was given to these 18,000 employees.”

“Can you tell me that you have not received a royalty from any entity that you ever oversaw the distribution of money in research grants?” Paul continued.

Watch the tense exchange above.

Thank you for visiting Hannity.com. You are about to leave
Hannity.com and proceed to a site owned and operated by a third party.
Hannity.com has no control over the content of this third-party site.
Click OK to proceed.
OK
X
You may if you would no longer like to receive a newsletter.
You have been successfully unsubscribed!
Please see our Terms of Use and Privacy Notice .
If you have any questions or concerns please contact us.